CRC Clinical Trial
Official title:
Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
The study aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure.
The study is planned as a single arm, open trial will include up to 30 patients, aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure. Subjects will be enrolled at up to 3 clinical sites in Israel. Subjects who meet the eligibility criteria will be required to follow a standard bowel preparation instruction. Patients will be asked to record and provide their diet and bowel movements in the provided diary log at time of their scheduled colonoscopy (Diary log is provided in appendix C) and to complete a satisfaction questionnaire include feedback on the procedure and on specific aspects related to the preparation regime. Following the procedure a telephone follow-up will be conducted at 48 hours (± 48 hours) post Pure-Vu procedure to assess patient well-being and capture any adverse events. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05002270 -
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04981119 -
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
|
||
| Active, not recruiting |
NCT01308086 -
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
|
Phase 3 | |
| Active, not recruiting |
NCT04585035 -
Study to Evaluate D-1553 in Subjects With Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03665285 -
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03336658 -
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
|
||
| Terminated |
NCT03875313 -
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05382377 -
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
|
Early Phase 1 | |
| Active, not recruiting |
NCT05314309 -
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
|
||
| Recruiting |
NCT06259552 -
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
|
Phase 1 | |
| Completed |
NCT05976282 -
Addressing Colorectal Cancer in South Florida Firefighters
|
N/A | |
| Recruiting |
NCT01593098 -
A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)
|
||
| Recruiting |
NCT03597581 -
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in 2nd Line RAS Mutant Advanced Colorectal Cancer
|
Phase 1 | |
| Terminated |
NCT05368688 -
Microbiome in Colorectal Cancer Onset and Progression
|
||
| Completed |
NCT03965845 -
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03601598 -
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05009329 -
FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China
|
Phase 1/Phase 2 | |
| Completed |
NCT02161549 -
Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy
|
N/A | |
| Active, not recruiting |
NCT04868773 -
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
|
Phase 1 |